We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Laboratory Medicine and Nosocomial Infections: the Present

By LabMedica International staff writers
Posted on 17 Feb 2010
Nosocomial infections or hospital acquired infections (HAIs) are generally diagnosed between 2 to 4 days after a patient is admitted to a hospital, as the patient develops a fever that is not explained by an underlying illness. In elderly patients, the first signs of infection may be rapid breathing or mental confusion.

Organisms responsible for nosocomial or hospital acquired infections (HAIs) need to be identified by the clinical laboratory as quickly as possible. This enables hospital staff to treat and isolate infected patients, choose appropriate treatment, and prevent overuse of antibiotics.

Laboratory tests are conducted including complete blood counts (CBCs), especially to look for an increase in infection-fighting white blood cells (WBCs); urinalysis, to search for white cells or evidence of blood in the urinary tract; cultures of the infected area, blood, sputum, urine, or other body fluids or tissue to find the causative organism. The laboratory also reviews all procedures performed that might have led to infection.

The organisms are retested for antibiotic sensitivity so that the patient can be treated quickly and effectively. Many bacteria have become resistant to standard antibiotic treatments, especially when patients with chronic illnesses are given antibiotic therapy for long periods. If this happens, the patient is treated with a more specific antibiotic to which the organism is sensitive.

The newest tests will facilitate earlier and more appropriate antibiotic treatment of patients. They should also lead to earlier implementation of infection control interventions that help prevent the transmission of the pathogens to other patients.


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080

Latest Microbiology News

Saliva Test Detects Implant-Related Microbial Risks
17 Feb 2010  |   Microbiology

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
17 Feb 2010  |   Microbiology

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
17 Feb 2010  |   Microbiology